Form 10-Q · Quarterly report
The J.M. Smucker Company 10-Q, filed Aug 26, 2026
- Filed
- CIK
- 0000091419
- Accession no.
- 0000091419-26-000080
Summary
The J.M. Smucker Company reported first-quarter fiscal 2027 net sales of $2.22 billion, up 5%, and net income of $324.3 million, or $3.03 per diluted share, compared with a net loss of $43.9 million a year earlier. Adjusted diluted earnings per share were $3.24, with higher gross profit attributed to lower costs, tariff refunds, higher net pricing, and favorable volume/mix.
Key points
- Net sales rose 5% to $2.2193 billion; net price realization contributed 4 percentage points and volume/mix added 1 point.
- Gross profit was $979.6 million versus $474.7 million a year earlier, and operating income was $511.6 million versus $45.6 million.
- U.S. Retail Coffee net sales rose 13% to $807.8 million and segment profit rose 124% to $300.0 million, helped by tariff refunds and higher net pricing.
- Sweet Baked Snacks net sales fell 7% to $236.5 million and segment profit fell 13% to $29.9 million on unfavorable volume/mix and higher costs.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Results of Operations Three Months Ended July 31, 2026 2025 % Increase (Decrease) Net sales $ 2,219.3 $ 2,113.3 5 % Gross profit $ 979.6 $ 474.7 106 % of net sales 44.1 % 22.5 % Operating income $ 511.6 $ 45.6 n/m % of net sales 23.1 % 2.2 % Net income (loss): Net income (loss) $ 324.3 $ (43.9) n/m Net income (loss) per common share – assuming dilution $ 3.03 $ (0.41) n/m Adjusted gross profit (A) $ 950.2 $ 743.2 28 % of net sales 42.8 % 35.2 % Adjusted operating income (A) $ 540.7 $ 370.3 46 % of net sales 24.4 % 17.5 % Adjusted income: (A) Income $ 346.5 $ 203.4 70 Earnings per share – assuming dilution $ 3.24 $ 1.90 71 (A)We use non-GAAP financial measures…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.